BUZZ—US Stock Market Trends: Estée Lauder, PTC, Vaxcyte

路透社2026/10/05 10:42

Show original

Search string for checking individual stock movements in the workspace: STXBZ "Today's Outlook" bulletin: https://refini.tv/3LI4BU7 "Morning News Brief": https://refini.tv/3dKUyB8 Reuters, October 5 - On Monday, U.S. stock index futures edged lower as technology stocks pulled back after reaching historic highs. With Treasury yields and oil prices still elevated, investors are seeking new clues about the direction of monetary policy. .N ** Vaxcyte PCVX.O: Market spotlight—Vaxcyte's stock surged after successful late-stage clinical trials for its pneumococcal vaccine nL4N45R0K0 ** Estée Lauder EL.N: Highlight—Barclays has upgraded Estée Lauder to "overweight," sending the stock higher nL6N45R0HX ** PTC PTC.O: Market news—Schneider Electric agreed to acquire PTC for $22.6 billions, driving the stock up nL6N45R0HV (Note: For convenience, Reuters provides automated translations of its reports into several other languages for non-English speakers. Automated translations may contain errors or lack necessary context, so Reuters does not guarantee their accuracy. They are provided solely for readers' convenience. Reuters assumes no liability for any damages or losses resulting from the use of automated translation tools.)

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Search string used in workspaces to query the price trend of a single stock: STXBZ

"Today's Outlook" Bulletin: https://refini.tv/3LI4BU7

"Morning News Brief": https://refini.tv/3dKUyB8

Reuters, October 5 - On Monday, US stock index futures edged lower as technology stocks retreated after hitting historic highs. With government bond yields and oil prices remaining elevated, investors are seeking new clues regarding the direction of monetary policy. .N

** Vaxcyte PCVX.O:

Market Focus — Vaxcyte shares surged following the successful late-stage clinical trial of its pneumococcal vaccine nL4N45R0K0

** Estée Lauder EL.N:
Hot Topic — Barclays upgraded Estée Lauder's rating to "Overweight", shares rise nL6N45R0HX

** PTC PTC.O:
Market Dynamics — Schneider Electric agreed to acquire PTC for $22.6 billion, shares jump nL6N45R0HV

(To facilitate non-native English speakers, Reuters has automated the translation of its reports into several other languages. Due to potential errors in automated translation or missing required context, Reuters does not guarantee the accuracy of the automated translation and offers the translation solely for readers’ convenience. Reuters bears no responsibility for any damage or loss caused by the use of the automated translation feature.)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

11:12 AM EDT, 10/05/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week lower late Monday morning, declining 0.14% to 1,883.96 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by lender Banco Santander (SAN) and brewing company Anheuser-Busch InBev (BUD), which advanced 3.2% and 0.8% respectively. They were followed by 3D printer company Materialise (MTLS) and internet browser company Opera (OPRA), which were up 0.6% and 0.3% respectively. The decliners from continental Europe were led by biopharmaceutical company Nokia (NOK) and biopharmaceutical company Cellectis (CLLS), which lost 3.2% each. They were followed by biopharmaceutical company DBV Technologies (DBVT) and petroleum refiner Equinor (EQNR), which decreased 0.9% and 0.4%, respectively. The gainers from the UK were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and software firm Endava plc (DAVA), which climbed 17% and 1.6% respectively. They were followed by medical device maker Smith & Nephew (SNN) and biotech firm Trinity Biotech (TRIB), which increased 1.2% and 1.4% respectively. The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which dropped 3.9% and 1.4% respectively. They were followed by hospitality company InterContinental Hotels Group (IHG) and pharmaceutical company GSK (GSK), which fell 1.1% and 1% respectively.

MT newswire•2026/10/05 15:12

Bitcoin Returns Reliant on Major Days -- Market Talk

1105 ET - Bitcoin's strong year-over-year returns are more linked to single days of strong moves, according to Zach Pandl of Grayscale in a note. Pandl says removing bitcoin's five best trading days reduces its three-year return from 225% to 95%, with the return falling to 27% without its 10 best days. If you remove the top fifteen days, it turns a three-year gain into an 11% loss. By comparison, removing the Nasdaq's fifteen best days reduces its cumulative return from 109% to 21%. "Given BTC's return and volatility profile, investors looking for long-term capital appreciation can avoid trying to time the market and instead seek consistent, long-term exposure to the asset," Pandl says. Bitcoin is down 0.2% to $85,610, while ethereum falls 0.2% to $2,701. (kirk.maltais@wsj.com) (END) Dow Jones Newswires October 05, 2026 11:05 ET (15:05 GMT)

Dow Jones•2026/10/05 15:05